title: Proper definitions of MRI contrast enhancement in liver tumors.
authors.forename: Yicheng
authors.initials: Y
authors.lastname: Ni
authors.forename: Feng
authors.initials: F
authors.lastname: Chen
authors.forename: Huaijun
authors.initials: H
authors.lastname: Wang
authors.forename: Yuanbo
authors.initials: Y
authors.lastname: Feng
authors.forename: Junjie
authors.initials: J
authors.lastname: Li
authors.forename: Yansheng
authors.initials: Y
authors.lastname: Jiang
mesh_terms: D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000503:physiopathology; D003287:Contrast Media / Q000493:pharmacokinetics; D019786:Gadolinium DTPA / Q000493:pharmacokinetics; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000503:physiopathology; D008279:Magnetic Resonance Imaging / Q000379:methods*; D029362:Organic Anion Transporters, Sodium-Independent / Q000235:genetics; D051381:Rats; D000074542:Solute Carrier Organic Anion Transporter Family Member 1B3
chemical_list: D003287:Contrast Media; D029362:Organic Anion Transporters, Sodium-Independent; C421209:SLCO1B3 protein, human; D000074542:Solute Carrier Organic Anion Transporter Family Member 1B3; C073590:gadolinium ethoxybenzyl DTPA; D019786:Gadolinium DTPA